Recent studies on fucosylated glycoforms of other liver-secreted proteins, namely haptoglobin, kininogen, α1-antitrypsin and Golgi protein 73 have shown the promising potential of these glycobiomarkers for differential diagnosis of HCC versus cirrhosis with improved sensitivity and specificity [85, 86]. This evidence concerns the gene HP and hepatocellular carcinoma.